GeminIQ Website Logo

Viewing CCEL free

Subscribe for full history, 50+ metrics, screener, watchlist...

CRYO CELL INTERNATIONAL INC

CCEL

Companies in Services-Misc Health & Allied Services, NEC

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-05-31
2026-02-28
2025-11-30
2025-08-31
2025-05-31
2025-02-28
2024-11-30
2024-08-31
2024-05-31
2024-02-29
2023-11-30
2023-08-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
100000100001
Marketable Securities Current
333343321111
Accounts Receivable Net Current
777777777776
Prepaid Expense Current
101111111111
Inventory Net
000111111111
Other Assets Current
011000000000
Derivative Fair Value Of Derivative Asset
------000000
Assets Current
1111121213131311109910
Property Plant And Equipment Net
212121212122222222222119
Long Term Investments And…
Intangible Assets Net Excluding Goodwill
111111111111
Inventory Noncurrent
111555555559
Goodwill
222222222222
Deferred Income Tax Assets Net
242424212121212020202014
Operating Lease Right Of Use Asset
111111111111
Other Assets Noncurrent
292929303030303030313141
Assets
616162636464656363626170
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
333323222333
Accrued Liabilities Current
334234633452
Notes Payable Current
000000000000
Lines Of Credit Current
022375424213
Operating Lease Liability Current
000000000000
Contract With Customer Liability Current
99101010910101091010
Liabilities Current
161820182222221719192119
Liabilities Noncurrent
Contract With Customer Liability Noncurrent
535251504948474544434140
Long Term Notes Payable
888888888888
Operating Lease Liability Noncurrent
000100111111
Other Long Term Debt Noncurrent
111111111111
Business Combination Contingent Consideration Liab…
------000001
Other Sundry Liabilities Noncurrent
0000000-----
Other Liabilities Noncurrent
636261605857565554535151
Liabilities
787980788079787273727270
Commitments And Contingencies
000000000000
Stockholders Equity
Preferred Stock Value
000000000000
Common Stock Value
000000000000
Additional Paid In Capital Common Stock
454545454545444444444343
Treasury Stock Value
-25-25-25-25-25-25-25-25-25-24-23-23
Retained Earnings Accumulated Deficit
-38-38-38-35-35-35-33-29-30-31-31-20
Stockholders Equity
-18-18-19-15-16-15-13-10-11-10-11-0
Liabilities And Stockholders Equity
616162636464656363626170
Allowance For Doubtful Accounts Receivable Current
444444444444
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
111111111111
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
202020202020202020202020
Common Stock Shares Issued
151515151515151515151515
Shares Outstanding
888888888888

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-5.99%-4.63%-8.99%---------
2025-9.34%-4.08%-6.66%-0.20%-7.33%-7.54%-7.69%-12.31%-24.62%-8.24%1.18%6.47%
202425.71%30.23%10.59%-1.69%-5.20%-10.67%49.49%55.13%34.33%-16.71%-26.33%-36.58%
2023------0.60%15.87%14.09%26.93%48.51%78.22%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-05-31
2026-02-28
2025-11-30
2025-08-31
2025-05-31
2025-02-28
2024-11-30
2024-08-31
2024-05-31
2024-02-29
2023-11-30
2023-08-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.71
0.62
0.59
0.63
0.60
0.58
0.58
0.61
0.52
0.49
0.45
0.54
Quick Ratio
0.66
0.58
0.54
0.56
0.54
0.51
0.52
0.54
0.45
0.42
0.39
0.44
Working Capital
-4.63M
-6.69M
-8.03M
-6.78M
-8.70M
-9.21M
-9.04M
-6.76M
-9.29M
-9.92M
-11.41M
-8.63M
Leverage & Debt
Debt to Equity
-4.42
-4.31
-4.32
-5.26
-5.14
-5.39
-5.89
-7.58
-6.82
-6.97
-6.55
-4,319.28
Interest Coverage TTM
-0.05
0.09
0.23
1.86
1.64
1.77
1.87
-9.76
-10.46
-9.64
-7.81
2.16
Debt Ratio
1.29
1.30
1.30
1.23
1.24
1.23
1.20
1.15
1.17
1.17
1.18
1.00
Efficiency & Turnover
Asset Turnover TTM
0.50
0.50
0.50
0.50
0.50
0.51
0.51
0.48
0.48
0.49
0.50
0.46
Days Sales Outstanding TTM
81.15
81.84
81.84
78.79
78.52
79.24
79.22
76.30
77.94
77.08
73.48
68.86
Receivables Turnover TTM
4.50
4.46
4.46
4.63
4.65
4.61
4.61
4.78
4.68
4.74
4.97
5.30
Per Share Metrics
Diluted EPS TTM
-0.31
-0.33
-0.30
-0.06
-0.02
0.02
0.05
-1.09
-1.13
-1.17
-1.14
0.30
Free Cash Flow Per Share TTM
0.76
0.61
0.65
0.77
0.73
0.66
0.44
0.38
-0.06
-0.00
0.25
0.34
Dividend Per Share TTM
0.25
0.35
0.60
0.60
0.60
0.50
0.25
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
77.93%
77.47%
76.63%
76.78%
75.94%
75.50%
75.15%
74.12%
73.86%
73.26%
73.23%
72.77%
Operating Profit Margin TTM
-0.33%
0.61%
1.53%
13.63%
11.93%
11.57%
10.88%
-39.49%
-40.46%
-41.97%
-39.26%
13.70%
Net Profit Margin TTM
-7.92%
-8.52%
-7.70%
-1.49%
-0.54%
0.40%
1.26%
-28.04%
-29.38%
-31.02%
-30.38%
8.02%
Growth Metrics
Net Revenue Growth (1Y)
-2.69%
-2.56%
-1.31%
-0.29%
1.10%
2.33%
2.05%
1.95%
1.93%
1.52%
3.32%
4.49%
Net Income Growth (1Y)
1,339.81%
-2,170.66%
-704.18%
-94.69%
-98.16%
-101.32%
-104.22%
-456.17%
-505.57%
-459.63%
-443.57%
93.32%
EPS Growth (1Y)
1,344.22%
-2,177.61%
-708.82%
-94.69%
-98.15%
-101.35%
-104.33%
-466.10%
-515.94%
-467.85%
-448.71%
95.74%
Valuation Metrics
P/E TTM
-11.01
-10.28
-14.28
-79.97
-241.51
481.87
164.90
-5.12
-6.56
-4.04
-4.28
18.13
P/B TTM
-1.53
-1.49
-1.86
-2.55
-2.66
-4.23
-5.02
-4.78
-5.68
-3.80
-3.70
-2,810.53
P/S TTM
0.87
0.88
1.10
1.19
1.29
1.93
2.07
1.43
1.93
1.25
1.30
1.45
Market Cap
27.15M
27.39M
34.70M
37.87M
41.37M
62.02M
66.31M
45.67M
60.96M
39.33M
40.77M
45.43M
Enterprise Value
34.92M
37.06M
45.03M
49.19M
56.27M
74.82M
77.74M
56.20M
73.25M
49.61M
50.18M
56.20M
Calculated Values
Free Cash Flow TTM
6.11M
4.94M
5.25M
6.18M
5.94M
5.31M
3.61M
3.09M
-512.24K
-2.13K
2.08M
2.86M
Net Debt
7.77M
9.67M
10.33M
11.32M
14.90M
12.80M
11.44M
10.53M
12.28M
10.29M
9.41M
10.77M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-09-18Purchase
Owner: Portnoy, David
Title: Chairman, Co-CEO
Shares: 3,411
Price/Share: $4.46
Value: $15,213.06
Shares Owned: 827,344
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2025-09-10Purchase
Owner: Portnoy, David
Title: Chairman, Co-CEO
Shares: 7,178
Price/Share: $4.42
Value: $31,726.76
Shares Owned: 811,920
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2025-08-27Purchase
Owner: Portnoy, David
Title: Chairman, Co-CEO
Shares: 14,078
Price/Share: $4.43
Value: $62,365.54
Shares Owned: 247,757
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2025-08-19Purchase
Owner: Portnoy, David
Title: Chairman, Co-CEO
Shares: 885
Price/Share: $4.37
Value: $3,867.45
Shares Owned: 135,721
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2025-08-14Purchase
Owner: Portnoy, David
Title: Chairman, Co-CEO
Shares: 5,826
Price/Share: $4.17
Value: $24,294.42
Shares Owned: 122,838
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
6.61%
Inst. Shares: 532,695
Shares Outstanding: 8,055,150
2025-12-31
12.18%
Inst. Shares: 982,790
Shares Outstanding: 8,068,777
2025-09-30
12.27%
Inst. Shares: 988,339
Shares Outstanding: 8,057,780
2025-06-30
12.32%
Inst. Shares: 995,201
Shares Outstanding: 8,080,161
2025-03-31
12.75%
Inst. Shares: 1,030,389
Shares Outstanding: 8,082,159

CRYO CELL INTERNATIONAL INC (CCEL) — SEC Financial Statements & Analysis

CRYO CELL INTERNATIONAL INC (CCEL) is a services-misc health & allied services, nec company, incorporated in DE. CRYO CELL INTERNATIONAL INC trades on NYSE as: CCEL. Based on its latest SEC filing (Form 10-Q, period ending 2026-05-31), CRYO CELL INTERNATIONAL INC reported a -2.69% year-over-year revenue growth, a Gross Profit Margin of 77.93% (TTM), a Debt-to-Equity ratio of -4.42x, a Price-to-Sales (P/S) ratio of 0.87x (TTM), a Price-to-Book (P/B) ratio of -1.53 (TTM), at a market cap of $27.15M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
-2.69%
Gross Profit Margin TTM
77.93%
Debt To Equity
-4.42x
P/S TTM
0.87x
P/B TTM
-1.53
Market Cap
$27.15M

Data as of 2026-05-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CRYO CELL INTERNATIONAL INC in?

CRYO CELL INTERNATIONAL INC (CCEL) operates in the Services-Misc Health & Allied Services, NEC industry.

What is CCEL's market cap?

CRYO CELL INTERNATIONAL INC (CCEL) has a market capitalization of $27.15M as of 2026-05-31.

What exchange does CCEL trade on?

CRYO CELL INTERNATIONAL INC (CCEL) trades on the NYSE.

Where is CRYO CELL INTERNATIONAL INC incorporated?

CRYO CELL INTERNATIONAL INC is incorporated in DE.

Research Faster.
Invest Smarter.

CRYO CELL INTERNATIONAL INC (CCEL) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.